Efficacy of short‐term dexamethasone therapy in acute‐on‐chronic pre‐liver failure
Efficacy of short‐term dexamethasone therapy in acute‐on‐chronic pre‐liver failure
复制标题
DOI:
10.1111/j.1872-034x.2010.00740.x
复制
发表时间:
2011-01
影响因子:
4.2
通讯作者:
Xu-qing Zhang;Li Jiang;J. You;Yu-Yuan Liu;Jing Peng;Huiyan Zhang;Bao-yan Xu;Q. Mao
中科院分区:
文献类型:
--
作者:
Xu-qing Zhang;Li Jiang;J. You;Yu-Yuan Liu;Jing Peng;Huiyan Zhang;Bao-yan Xu;Q. Mao
Aim: Acute‐on‐chronic pre‐liver failure (pre‐ACLF) is defined as a severe acute episode of chronic hepatitis B characterized by serum bilirubin of 171 µmol/L or more, alanine aminotransferase of five times or more the upper limit of normal and prothrombin activity of more than 40%, having a potential for progression to acute‐on‐chronic liver failure (ACLF). This study is to evaluate the efficacy of short‐term dexamethasone in pre‐ACLF.